Innovation Agency

What Innovation Agency does

Innovation Agency is a UK-based academic health science network (AHSN), founded in 2013 and headquartered in Daresbury. Its web presence under the innovationagencynwc.nhs.uk domain indicates affiliation with the National Health Service and a geographic remit across the North West Coast of England. The organization operates with a workforce of 51–100 employees and is led by Chief Executive Officer Phil Jennings.

As an AHSN, the entity is structurally embedded within the NHS regional innovation architecture, which historically has focused on accelerating the adoption and spread of evidence-based healthcare innovations across NHS trusts, primary care, and academic partners. The firmographic record classifies the entity as for-profit and privately held, but the.nhs.uk domain and AHSN designation are characteristic of publicly-funded bodies operating within the NHS commissioning framework; no formal ownership, parent entity, or governance disclosures are available to reconcile this.

The available source material is materially incomplete. The organization's public website was inaccessible at the time of collection (displaying a default cPanel hosting error page under source), and no products, services, customers, partnerships, funding events, pricing, or financial figures were disclosed. Consequently, the agency's specific programme portfolio, revenue mechanics, and go-to-market model cannot be characterized with confidence beyond its general positioning as a regional NHS innovation intermediary.

Name

Innovation Agency

Website

https://innovationagencynwc.nhs.uk

Company type

Private

Founded year

2013

Headcount range

51–100 employees

Short description

Innovation Agency is a UK-based academic health science network affiliated with the NHS, founded in 2013 and headquartered in Daresbury, serving the North West Coast health innovation ecosystem with 51–100 employees.

Ownership category

akta.pro rank

Product category

Healthcare Innovation Services

NAICS

Scientific Research and Development Services (5417), Management Consulting Services (54161)

SIC

Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

akta.pro secondary industries

Science, Technology & Innovation Administration (National R&D Policy) (BPAIAAAK), Health Technology Assessment (HTA) & Reimbursement Policy Bodies (HLAJACAF)

Keywords

• Academic health science network
• Healthcare innovation services
• NHS innovation network
• Clinical innovation adoption
• Health system transformation

Headquarters

HQ city

Daresbury

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Core offering

Innovation Agency operates as an academic health science network based in Daresbury, United Kingdom, convening NHS, academic, and industry stakeholders to identify, develop, and spread healthcare innovations across the North West Coast region. Founded in 2013, the organization functions as a regional AHSN intermediary supporting the translation of research and innovation into improvements in patient care and population health outcomes within the NHS.

Product overview

No product or service information available. The source content consists of a default hosting error page indicating the website at innovationagencynwc.nhs.uk is currently inaccessible due to DNS or server configuration issues.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Expansion highlights1 record

Others

• Catalent (now part of Novo Holdings): Catalent is a global contract development and manufacturing organization serving pharma and biopharma with development and delivery services. Included as an adjacent 'others' peer because both Catalent and Innovation Agency sit in the broader health-innovation delivery ecosystem, even though Catalent operates commercially in manufacturing rather than NHS innovation brokering.

Direct peers

• Health Innovation Manchester: Health Innovation Manchester is the Academic Health Science Network (and innovation accelerator) for the Greater Manchester region of England. It is the closest geographic and functional peer to the Innovation Agency, operating an identical AHSN mandate of brokering NHS-academia-industry collaboration to spread proven innovation.
• Oxford Academic Health Partners: Oxford Academic Health Partners is an AHSN-affiliated partnership in the Oxford region linking NHS providers, the University of Oxford, and industry. Directly comparable as an AHSN-style intermediary performing health innovation translation and adoption support across a defined NHS geography.
• Imperial College Health Partners: Imperial College Health Partners is the AHSN for North West London. Another direct AHSN peer performing the same innovation-brokering function for its regional NHS footprint, funded and structured comparably to Innovation Agency.
• UCLPartners: UCLPartners is an Academic Health Science Network covering North East and North Central London and the South East. Comparable to Innovation Agency as a peer AHSN delivering innovation adoption programs across an NHS region, with similar tri-party brokering role between providers, universities, and industry.

Regional players

• MedCity: MedCity is the life sciences accelerator for the Greater South East of England, supporting collaboration between NHS, academia, and industry in medtech, biotech, and digital health. Comparable to Innovation Agency in mission but regionally focused on London and the South East rather than the North West Coast.

Broad incumbents

• NICE (National Institute for Health and Care Excellence): NICE is the UK Health Technology Assessment body that evaluates clinical and cost effectiveness of health innovations. Comparable as a public-sector organization shaping which innovations the NHS adopts — overlapping with Innovation Agency's adoption-brokering role, but operating at national HTA policy level rather than regional implementation.
• NHS England Innovation, Research and Life Sciences: NHS England's central Innovation, Research and Life Sciences directorate commissions and oversees the AHSN network nationally. It is a broad incumbent — not a direct competitor but the parent commissioner that defines Innovation Agency's mandate, funding envelope, and policy direction.
• NIHR (National Institute for Health and Care Research): NIHR is the UK's largest funder of health and care research, funding research infrastructure, clinical trials, and evidence synthesis. A broad incumbent in the same health innovation evidence ecosystem that Innovation Agency serves, with overlapping interests in translating research into NHS practice.

Emerging players

• Health Data Research UK: Health Data Research UK is the national institute for health data science, uniting the UK's health data to enable discoveries that improve health. An emerging player with partial overlap to Innovation Agency — both work at the intersection of NHS data, research, and innovation adoption, but HDR UK focuses specifically on data infrastructure rather than regional brokering.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks4 records

Key highlights5 records

Customer concentration

• Xx.com/innovationnwc
• Facebookfacebook.com/InnovationNWC
• LinkedInlinkedin.com/company/north-west-coast-academic-health-science-network

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innovation Agency